EurekaMag.com logo
+ Translate

Recent developments in gonorrhea and pelvic inflammatory disease


, : Recent developments in gonorrhea and pelvic inflammatory disease. Journal of Medicine 14(4): 281-305

Gonorrhea remains the most commonly reported sexually transmitted infection, with a total of 2-2.5 million cases occurring annually in the United States. The annual incidence of gonococcal and nongonococcal pelvic inflammatory disease (PID) is 600,000-1,000,000 cases, 10-15% of which result in infertility due to bilateral tubal occulusion. PID results from ascending infection with sexually transmitted pathogens or components of the normal vaginal flora, or both. Uncomplicated gonorrhea usually is best treated with a single dose of ampicillin or procaine penicillin G (given with probenecid) or spectinomycin, in each case followed by a 7 day course of tetracycline or doxycycline to eradicate coexisting chlamydial infection. PID, both gonococcal and non-gonococcal, ideally should be treated in the hospital with parenteral antibiotics. Regimens utilizing various combinations of doxycycline, cefoxitin, clindamycin, aminoglyocosides, or metronidazole are recommended. The sexual partners of patients with gonorrhea or with PID (non-gonococcal as well as gonococcal) should be routinely examined and treated.

(PDF 0-2 workdays service)

Accession: 006269412

PMID: 6423757

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Grimes, D.A., 1987: Intrauterine devices and pelvic inflammatory disease: recent developments. The potential relationship between use of IUDs and pelvic inflammatory disease (PID) is one of the most important issues in contraception today. A number of large sophisticated studies published since mid-1980 have clarified this association. All...

Adler M.W., 1980: Trends for gonorrhea and pelvic inflammatory disease in england and wales uk and for gonorrhea in a defined population. American Journal of Obstetrics & Gynecology 138(7 PART 2): 901-904

Adler, M.W., 1980: Trends for gonorrhea and pelvic inflammatory disease in England and Wales and for gonorrhea in a defined population. The trends for gonorrhea and pelvic inflammatory disease in England and Wales are presented. Reported cases of gonococcal infection during a 12 year period, 1966 through 1977, were examined to determine incidence trends. Incidence rates by sex and...

Cates W.Jr; Wasserheit J.N., 1990: Gonorrhea chlamydia and pelvic inflammatory disease. Current Opinion in Infectious Diseases 3(1): 10-19

Rothman, K.J.; Lanza, L.; Lal, A.; Peskin, E.G.; Dreyer, N.A., 1996: Incidence of pelvic inflammatory disease among women treated for gonorrhea or chlamydia. Background: No estimate exists of the incidence of pelvic inflammatory disease (PID) after the occurrence of a recent bout of sexually transmitted disease (STD). Methods: We used a computerized data file of prescriptions and medical encounters fro...

Sault, A.J.; Podgorny, G., 1976: Diagnosis and treatment of pelvic inflammatory disease and gonorrhea in the emergency department. One hundred emergency department charts on cases of suspected pelvic inflammatory disease (PID) were reviewed to determine method of diagnosis and treatment. Seventy-three gonococcus smears, 60 gonococcus cultures, and 53 VDRL tests for syphilis w...

Ryden G.; Fahraeus L.; Molin L.; Ahman K., 1979: Do contraceptives influence the incidence of pelvic acute inflammatory disease in women with gonorrhea?. The influence of different contraceptive techniques on the incidence of pelvic inflammatory disease (PID) in 672 patients with gonorrhoea was studied. The lowest frequency of PID was found in patients using hormonal contraceptives (Group A), 8.8%...

Bell T.A.; Holmes K.K., 1984: Age specific risks of syphilis gonorrhea and hospitalized pelvic inflammatory disease in sexually experienced usa women. Data from the Centers for Disease Control (Atlanta, Georgia, USA), National Hospital Discharge Survey, USA Census, and surveys of sexual activity in adolescent women was used to estimate age-specific rates of infectious syphilis, gonorrhea and pel...

Burnett, A.M.; Anderson, C.P.; Zwank, M.D., 2012: Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. The aim of this study was to determine the rates of laboratory confirmed gonorrhea (GC) and chlamydia (CT) in emergency department (ED) patients with pelvic inflammatory disease (PID) and cervicitis who were diagnosed clinically and treated empiri...

Sufrin, C.B.; Postlethwaite, D.; Armstrong, M.Anne.; Merchant, M.; Wendt, J.Moro.; Steinauer, J.E., 2013: Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease. To evaluate the relationship between Neisseria gonorrhea and Chlamydia trachomatis screening strategies and risk of pelvic inflammatory disease (PID) after intrauterine device (IUD) insertion. We conducted a retrospective cohort study of all IUD i...